GENTECH DIAGNOSTICS PVT. LTD.- HPV DNA Test Kit HBV DNA Quantification Test  Kit CMV DNA Quantification Test  Kit Real Time PCR HBV DNA Quantification  Real Time PCR HBV DNA GenotypeColposcope Digital Imaging System

Home | About Us | Enquiry | Download | Contact Us
HPV DNA Test Kit
 General Brochure                                              Patient Information
HBV DNA Quantification Test  Kit
CMV DNA Quantification Test  Kit
Chlamydia  DNA Test  Kit
Gonorrhoea DNA Test  Kit
Cytology Testing
Real Time PCR HBV DNA Quantification  
Real Time PCR HBV DNA Genotype  
Real Time PCR HCV DNA Quantification  

Gentech Diagnostics Pvt. Ltd.
234A, First Floor,Chandi Plaza,
Sant Nagar, East of Kailash
New Delhi-110 065
Tel:+91-11-2644 5263, 2642 9843 Mo: 09810314638
Fax:+91-11-2644 5269
E mail: info_gentech@satyam.net.in

"Click here to view Partner Companies for whome, we support & distribute in Indian sub-continent"
 

Women’s Health Care

Cervical Cancer Diagnosis Prevention & Management

NEW AGE, NEW CULTURE

21st Century Concept


Facts about CERVICAL CANCER

Cervical cancer is a leading cause of death due to cancer among Asian women and poses serious public health concern. In India, it is the most common malignancy according to National Cancer Registry Program, 1988-89 report. There are nearly a million cervical cancer cases reported with nearly quarter of a million new cases being added every year. The age adjusted cervical cancer incidence reported from some of the important cities of India per 100,000 women population is; Mumbai–19.4, Bangalore–26.4, Chennai–43.5, Delhi–30.1, Bhopal–24.3 & Barshi (Maharashtra)–26.2.
 

Human papillomavirus (HPV) is present in 99.7% cervical carcinomas1. In about 80% of sexually active women who get infected, HPV may clear it in 6-8 months2,3,4. Other 20% may develop cervical intraepithelial neoplasia (CIN)2 and its persistent presence may progress through PRECANCER stages to INVASIVE CANCER and may require radio- or chemotherapy or surgery.
 
The sensitivity of Pap smears could vary between 35 to 85% in correctly identifying high-grade  disease even in controlled studies5 against HPV testing ranging from 85 to 100%6.
The period of infection to Cancer development may be long, upto 15 years, challenging body’s immunity7.

Unlike other cancers, Cervical Cancer is 100% PREVENTABLE and also largely EASILY TREATABLE if detected in the early stages8.

          NATIONAL CLINICAL REFERENCE LABORATORY

AIM & OBJECTIVE : This facility in India has been set up as a support service to promote and popularize by enhanced awareness of the niche molecular diagnostic technologies and speciality tests in the areas of cancer and viral diseases meeting the international standards and at affordable Indian prices for the better patient care and modern health care management services.

the STATE-OF-THE-WORLD-TECHNOLOGY MOLECULAR pathology FACILITY IN DIAGNOSIS AND PREVENTION OF CERVICAL CANCER
                                                                         WITHIN INDIAN AFFORDABILITY

 


Copyright 2006-2007 Gentech Diagnostics  All rights reserved.